1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 4: 
Areas under the ROC curve for NAAx, NAAx/mIns, and finger-tapping speed at baseline
Accuracy to Differentiate Controls from Patients: Area (CI)aAccuracy to Differentiate Patients with ALS from Patients with PMA: Area (CI)
NAAx0.663 (0.510–0.816)0.750 (0.582–0.918).016
Finger-tapping speedb0.820 (0.709–0.932).0010.764 (0.608–0.919).011
NAAx/mIns0.712 (0.573–0.850).0240.649 (0.463–0.836)
  • a All patient groups included.
  • b Finger-tapping speed: (L + R) / 2.